United Therapeutics (UTHR) Leases (2022)

United Therapeutics (UTHR) reported Leases of $12.2 million for Q3 2022.

United Therapeutics (UTHR) Leases (2022) Analysis & Trends

United Therapeutics (UTHR) has 1 years of Leases data on file, last reported at $12.2 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Haleon 89.33 Bn 87.46 Bn - -
2 Teva Pharmaceutical Industries 35.86 Bn 32.12 Bn 1.97 Bn 335.00 Mn
3 Zoetis 32.54 Bn 30.60 Bn 1.62 Bn 282.00 Mn
4 Takeda Pharmaceutical 27.63 Bn 23.57 Bn 4.39 Bn -
5 United Therapeutics 23.12 Bn 20.96 Bn 648.10 Mn -
6 RedHill Biopharma 21.80 Bn 21.80 Bn - 1.06 Mn
7 Viatris 20.26 Bn 18.46 Bn 1.16 Bn 253.00 Mn
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn 447.10 Mn
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn -
10 Vireo Growth 10.52 Bn 10.37 Bn 59.30 Mn 84.80 Mn

Historic Data

Download Data
DateValue
Sep 30, 2022 12.20 Mn